InMed Pharmaceuticals Inc. Insider Trading

INM

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Feb 2024.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Feb 2024

Feb 21, 2024

Get an email when INM's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 23	Adar1 Capital Management, LLC Large holder	Bought	4	$1.32	$5	<0.1%	Form 4
Oct 16 – 19	Adar1 Capital Management, LLC Large holder	Bought 2 parts	1,087	$1.32 average	1K	0.1%	Form 4
Oct 13 – 15	Adar1 Capital Management, LLC Large holder	Bought 3 parts	9,569	$1.33 average	13K	1.0%	Form 4
Oct 6 – 8	Adar1 Capital Management, LLC Large holder	Bought 3 parts	10,903	$1.33 average	14K	1.2%	Form 4
Oct 1 – 5	Adar1 Capital Management, LLC Large holder	Bought 3 parts	42,920	$1.33 average	57K	4.8%	Form 4
Sep 14 – 16	Daniel Schneeberger Large holder	Bought 3 parts	91,101	$1.30 average	118K	11%	Form 4
Jul 14 – 16	Vivo Opportunity Cayman Fund, L.p. Large holder	Bought 6 parts	20,546	$1.55 average	32K	2.6%	Form 4
Jul 15	Adar1 Capital Management, LLC Large holder	Bought	1,000	$1.56	2K	0.1%	Form 4
Jun 30 – Jul 2	Vivo Opportunity, LLC Large holder	Bought 6 parts	6,551	$1.55 average	10K	0.8%	Form 4
May 20 – Jun 8	Vivo Opportunity, LLC Large holder	Bought 18 parts	249,227	$1.57 average	392K	46%	Form 4
May 19	Daniel Schneeberger Large holder	Bought 3 parts	468,551	$1.54 average	722K	141%	Form 4

Oct 23
Adar1 Capital Management, LLC
Large holder · bought 4 at $1.32
$5
<0.1% of stake
Oct 16 – 19
Adar1 Capital Management, LLC
Large holder · bought 1,087 at avg $1.32
1K
0.1% of stake
Oct 13 – 15
Adar1 Capital Management, LLC
Large holder · bought 9,569 at avg $1.33
13K
1.0% of stake
Oct 6 – 8
Adar1 Capital Management, LLC
Large holder · bought 10,903 at avg $1.33
14K
1.2% of stake
Oct 1 – 5
Adar1 Capital Management, LLC
Large holder · bought 42,920 at avg $1.33
57K
4.8% of stake
Sep 14 – 16
Daniel Schneeberger
Large holder · bought 91,101 at avg $1.30
118K
11% of stake
Jul 14 – 16
Vivo Opportunity Cayman Fund, L.p.
Large holder · bought 20,546 at avg $1.55
32K
2.6% of stake
Jul 15
Adar1 Capital Management, LLC
Large holder · bought 1,000 at $1.56
2K
0.1% of stake
Jun 30 – Jul 2
Vivo Opportunity, LLC
Large holder · bought 6,551 at avg $1.55
10K
0.8% of stake
May 20 – Jun 8
Vivo Opportunity, LLC
Large holder · bought 249,227 at avg $1.57
392K
46% of stake
May 19
Daniel Schneeberger
Large holder · bought 468,551 at avg $1.54
722K
141% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch INM, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with INM

CompareIntrinsic value

PCYNProcyon Corporation

$0.18+0.00%20

RANIRani Therapeutics Holdings Inc.

$0.57+3.02%10

PTPIPetros Pharmaceuticals Inc.

$0.00+70.00%35

BOLTBolt Biotherapeutics Inc.

$6.54-0.46%25

TRDAEntrada Therapeutics Inc.

$5.06+7.20%10

KYNBKyntra Bio, Inc.

$3.96-8.12%20

ENSCEnsysce Biosciences Inc.

$0.37-2.20%40

CAMPCamp4 Therapeutics Corp.

$3.74-2.35%40

Spot a number that looks wrong? Check it in INM's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing INM

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.